Patients
Physicians
Sponsors
Oncologists
About Us
News
ENG
Last updated 5 months ago
Share
Short-course Benznidazole Treatment to Reduce Trypanosoma Cruzi Parasitic Load in Women of Reproductive Age
600 patients around the world
Available in
Argentina
Tulane University School of Public Health and Tropical Medicine
1
Research sites
600
Patients around the world
This study is for people with
Chagas disease
Requirements for the patient
From 13 Years
Female
Medical requirements
Inclusion criteria
Written informed consent from the mother.
T. cruzi seropositivity confirmed by at least two positive tests.
Live birth.
Exclusion criteria
Women residing outside of the provinces of Chaco, Santiago del Estero, or Tucumán.
Previous trypanocide treatment (BZN or nifurtimox).
Female sterilization; no intention to use modern contraception methods during treatment.
Positive pregnancy test.
History of severe alcohol abuse within two years; renal insufficiency.
Sites
Instituto de Efectividad Clínica y Sanitaria - IECS
Recruiting
Consult
View site
Dr. Emilio Ravignani 2024, CABA, Buenos Aires
View site
Consult
See details
Contact us
Contact us
Study
R01HD095587
Sponsor
Tulane University School of Public Health and Tropical Medicine
Study type
Interventional
Conditions
Chagas disease
Requirements
From 13 Years
Female
Unique study ID
clinicaltrials.gov
NCT03672487
About us
Our mission
Our team
Partners
FAQs
Medical news
Latest news
Studies
Interviews
Testimonials
Products
UEPM Onco
UEPM Physicians
Links
Downloads
English
Terms and Conditions
Privacy Policy
Change your consent
English
Terms and Conditions
Privacy Policy
Change your consent
English
Terms and Conditions
Privacy Policy
Change your consent